secwatch.observer — SEC 8-K summary
======================================

Issuer:     MSP Recovery, Inc. (MSPR)
CIK:        0001802450
Form:       8-K
Filed at:   2024-12-03T23:59:59+00:00
Accession:  0000950170-24-132744
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MSP Recovery regains Nasdaq compliance, reports $2M pharma settlement and Nomura waiver
--------------------------------------------------------------------------------

- Nasdaq confirmed bid price deficiency cured; Class A common stock continues listing on Nasdaq Global Market.
- Reached preliminary $2M settlement in pharmaceutical RICO case; settlement provides data to pursue other manufacturers.
- Ongoing settlement negotiations with P&C insurers and pharma/medical device manufacturers; five P&C settlements in 2024 totaling >$10M.
- Nomura waived up to $4M of promissory note obligations until March 2025 for operations, increasing liquidity.
- Acquired additional MSP claims with >$10.6B paid amount for $2M to enhance recovery efforts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802450/000095017024132744/0000950170-24-132744-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802450/000095017024132744/lifw-20241203.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-132744

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer